PRECIGEN INC
PRECIGEN INC
Aktie · US74017N1054 · PGEN · A2PZG1 (XNAS)
Übersicht Finanzkennzahlen
1,50 USD
10,05 % 0,14 USD
NASDAQ (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
06.06.2025 14:16

Aktuelle Kurse von PRECIGEN INC

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
PGEN
USD
06.06.2025 14:17
1,48 USD
1,33 USD
+11,28 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
8,94 % 12,83 % -2,63 % -22,54 % 91,46 % -15,43 % -53,89 %

Firmenprofil zu PRECIGEN INC Aktie

Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; and Intrexon Energy Partners II, LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.

Investierte Fonds

Folgende Fonds haben in investiert: PRECIGEN INC investiert:

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in Mio
42,33
Anteil (%)
0,10 %

Unternehmensdaten

Name PRECIGEN INC
Firma Precigen, Inc.
Symbol PGEN
Website https://www.precigen.com
Heimatbörse XNAS NASDAQ
WKN A2PZG1
ISIN US74017N1054
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Helen Sabzevari MPH, Ph.D.
Marktkapitalisierung 409 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,1 T
Adresse 20374 Seneca Meadows Parkway, 20876 Germantown
IPO Datum 2013-08-08

Kennungs-Wechsel

Datum Von Zu
03.02.2020 XON PGEN

Ticker Symbole

Name Symbol
Frankfurt I5X.F
NASDAQ PGEN

Weitere Aktien

Investoren die PRECIGEN INC die halten, haben auch folgende Aktien im Depot:
ALPHABET INC - CLASS C
ALPHABET INC - CLASS C Aktie
AMGEN INC
AMGEN INC Aktie
AUTODESK INC
AUTODESK INC Aktie
AXIS Capital Holdings Limited
AXIS Capital Holdings Limited Aktie
BITCOIN
BITCOIN Crypto
BOEING CO
BOEING CO Aktie
CHARTER COMMUNICATIONS INC - CLASS A
CHARTER COMMUNICATIONS INC - CLASS A Aktie
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
COSTAMARE INC
COSTAMARE INC Aktie
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Aktie
INTEL CORP
INTEL CORP Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
ProShares Trust ProShares Short Ether Strategy ETF
ProShares Trust ProShares Short Ether Strategy ETF ETF
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025